SIGA TECHNOLOGIES INC
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
PART I-FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements (Unaudited)
PART I - FINANCIAL INFORMATION
Item 1 - Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $99,269,756 | $150,145,844 |
| Accounts receivable | 12,089,010 | 21,130,951 |
| Inventory | 62,024,473 | 64,218,337 |
| Prepaid expenses and other current assets | 7,302,979 | 3,496,028 |
| Total current assets | 180,686,218 | 238,991,160 |
| Property, plant and equipment, net | 1,411,315 | 1,331,708 |
| Deferred tax asset, net | 12,104,765 | 11,048,118 |
| Goodwill | 898,334 | 898,334 |
| Other assets | 253,605 | 2,083,535 |
| Total assets | $195,354,237 | $254,352,855 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $1,260,762 | $1,456,316 |
| Accrued expenses and other current liabilities | 7,184,514 | 10,181,810 |
| Deferred IV TPOXX® revenue | 13,729,440 | 20,788,720 |
| Income tax payable | 127,815 | 21,690,899 |
| Total current liabilities | 22,302,531 | 54,117,745 |
| Other liabilities | 3,609,572 | 3,376,203 |
| Total liabilities | 25,912,103 | 57,493,948 |
| Commitments and contingencies | ||
| Stockholders’ equity | ||
| Common stock ($.0001 par value, 600,000,000 shares authorized, 71,369,274 and 71,091,616, issued and outstanding at September 30, 2024 and December 31, 2023, respectively) | 7,137 | 7,109 |
| Additional paid-in capital | 238,033,324 | 235,795,420 |
| Accumulated deficit | (68,598,327) | (38,943,622) |
| Total stockholders’ equity | 169,442,134 | 196,858,907 |
| Total liabilities and stockholders’ equity | $195,354,237 | $254,352,855 |
The accompanying notes are an integral part of these financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME/(LOSS) (UNAUDITED)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues | ||||
| Product sales and supportive services | $8,942,875 | $7,958,289 | $53,496,869 | $14,924,058 |
| Research and development | 1,066,906 | 1,276,882 | 3,753,658 | 8,512,303 |
| Total revenues | 10,009,781 | 9,235,171 | 57,250,527 | 23,436,361 |
| Operating expenses | ||||
| Cost of sales and supportive services | 1,620,510 | 896,537 | 17,157,508 | 3,021,145 |
| Selling, general and administrative | 4,822,591 | 5,999,761 | 18,228,786 | 14,660,828 |
| Research and development | 3,024,593 | 3,648,117 | 8,966,905 | 13,810,307 |
| Total operating expenses | 9,467,694 | 10,544,415 | 44,353,199 | 31,492,280 |
| Operating income/(loss) | 542,087 | (1,309,244) | 12,897,328 | (8,055,919) |
| Other income, net | 1,330,505 | 883,148 | 4,590,935 | 2,964,482 |
| Income/(Loss) before income taxes | 1,872,592 | (426,096) | 17,488,263 | (5,091,437) |
| (Provision)/Benefit for income taxes | (528,647) | 33,030 | (4,034,362) | 904,638 |
| Net and comprehensive income/(loss) | $1,343,945 | $(393,066) | $13,453,901 | $(4,186,799) |
| Basic income/(loss) per share | $0.02 | $(0.01) | $0.19 | $(0.06) |
| Diluted income/(loss) per share | $0.02 | $(0.01) | $0.19 | $(0.06) |
| Weighted average shares outstanding: basic | 71,368,585 | 71,084,735 | 71,191,019 | 71,453,397 |
| Weighted average shares outstanding: diluted | 71,766,503 | 71,084,735 | 71,853,341 | 71,453,397 |
The accompanying notes are an integral part of these financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net income/(loss) | $13,453,901 | $(4,186,799) |
| Adjustments to reconcile net income/(loss) to net cash used in operating activities: | ||
| Depreciation and other amortization | 407,692 | 400,702 |
| Stock-based compensation | 2,876,071 | 1,589,993 |
| Write down of inventory, net | 327,373 | 562,941 |
| Deferred income taxes, net | (1,056,647) | (1,647,191) |
| Deferred IV TPOXX® revenue | (7,059,280) | 10,240,000 |
| Changes in assets and liabilities: | ||
| Accounts receivable | 9,041,941 | 37,356,901 |
| Inventory | 2,676,093 | (26,240,079) |
| Prepaid expenses and other assets | (2,992,590) | (1,433,011) |
| Accounts payable, accrued expenses and other liabilities | (3,659,762) | 379,384 |
| Income tax payable | (21,563,085) | (1,255,240) |
| Net cash (used in)/provided by operating activities | (7,548,293) | 15,767,601 |
| Cash flows from investing activities: | ||
| Capital expenditures | (24,612) | (21,686) |
| Cash used in investing activities | (24,612) | (21,686) |
| Cash flows from financing activities: | ||
| Payment of employee tax obligations for common stock tendered | (638,139) | (214,794) |
| Repurchase of common stock | — | (11,072,511) |
| Payment of dividend | (42,665,044) | (32,135,118) |
| Cash used in financing activities | (43,303,183) | (43,422,423) |
| Net decrease in cash and cash equivalents | (50,876,088) | (27,676,508) |
| Cash and cash equivalents at the beginning of period | 150,145,844 | 98,790,622 |
| Cash and cash equivalents at end of period | $99,269,756 | $71,114,114 |
| Supplemental disclosure of non-cash financing activities: | ||
| Non-cash lease right-of-use asset and associated liability | $462,686 | $— |
| Issuance of common stock | $417,000 | $— |
| Issuance of common stock upon cashless exercise | $— | $87,540 |
The accompanying notes are an integral part of these financial statements
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. Condensed Consolidated Financial Statements
The financial statements of SIGA Technologies, Inc. (“we,” “our,” “us,” “SIGA” or the “Company”) are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission for quarterly reports on Form10-Q and should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended* December 31, 2023*, included in the Company's2023 Annual Report on Form10-K filed on* March 12, 2024 (the "2023 Form10*-K"). All terms used butnot defined elsewhere herein have the meaning ascribed to them in the2023 Form10-K. In the opinion of management, all adjustments (consisting of normal and recurring adjustments) considered necessary for a fair statement of the results of the interim periods have been included. The2023 year-end condensed consolidated balance sheet data were derived from the audited financial statements but donot include all disclosures required by U.S. GAAP. The results of operations for thethree andnine months ended* September 30, 2024*, arenot necessarily indicative of the results expected for the full year.
2. Summary of Significant Accounting Policies
Revenue Recognition
The Company accounts for revenue in accordance with ASC Topic606, Revenue from Contracts with Customers (“ASC606”). In all transactions, the Company is the principal as it controls the specified good or service before it is transferred to the customer and therefore recognizes revenue on a gross basis. A contract’s transaction price is allocated to distinct performance obligations and recognized as revenue when, or as, a performance obligation is satisfied. The Company accounts for shipping and handling activities as fulfillment costs rather than as an additional promised service. As of* September 30, 2024,the Company's active contractual performance obligations consist of the following: four performance obligations relate to research and development services; andsix relate to manufacture and delivery of product. The material performance obligations are referenced in Note3*. The aggregate amount of the transaction price allocated to current performance obligations as of* September 30, 2024* was $174.2 million. Current performance obligations represent the transaction price for which work hasnot been performed and excludes unexercised contract options. With respect to current obligations related to the manufacture and delivery of product, the Company expects such obligations to be mostly recognized as revenues within the next 12 months. With respect to the performance obligations related to research and development services, the Company expects such obligations to be recognized as revenue within the nextfour years as the specific timing for satisfying performance obligations is subjective and at times outside the Company's control.
Performance Obligations
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.
Contract modifications* mayoccur during the course of performance of our contracts. Contracts are often modified to account for changes in contract specifications or requirements. In most instances, contract modifications are for services that arenot* distinct, and, therefore, are accounted for as part of the existing contract.
The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A portion of the Company's revenue is derived from long-term contracts that span multiple years. All of the Company’s revenue related to current research and development performance obligations is recognized over time, because the customer simultaneously receives and consumes the benefits provided by the services as the Company performs these services. The Company recognizes revenue related to these services based on the progress toward complete satisfaction of the performance obligation and measures this progress under an input method, which is based on the Company’s cost incurred relative to total estimated costs. Under this method, progress is measured based on the cost of resources consumed (i.e., cost ofthird-party services performed, cost of direct labor hours incurred, and cost of materials consumed) compared to the total estimated costs to completely satisfy the performance obligation. Incurred costs represent work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer. The incurred and estimated costs used in the measure of progress includethird-party services performed, direct labor hours, and material consumed.
Contract Balances
The timing of revenue recognition, billings and cash collections* mayresult in billed accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) in the condensed consolidated balance sheets. Generally, amounts are billed as work progresses in accordance with agreed-upon contractual terms either at periodic intervals (monthly) or upon achievement of contractual milestones; as of September 30, 2024*, the accounts receivable balance in the condensed balance sheet includes approximately $2.8 million of unbilled receivables. This amount includes international sales that are billed under the terms specified in the International Promotion Agreement with Meridian Medical Technologies, LLC (“Meridian”). Under typical payment terms of fixed price arrangements, the customer pays the Company either performance-based payments or progress payments. For the Company’s cost-type arrangements, the customer generally pays the Company for its actual costs incurred, as well as its allocated overhead and G&A. Such payments occur within a short period of time from billing. When the Company receives consideration, or such consideration is unconditionally due, prior to transferring goods or services to the customer under the terms of a sales contract, the Company records deferred revenue, which represents a contract liability. During thenine months ended* September 30, 2024*, the Company recognized approximately $7.1 million of revenue that was included in deferred revenue at the beginning of the period.
5
Recent Accounting Pronouncements
In* November 2023,the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”)No. 2023-07, Segment Reporting (Topic280*): Improvements to Reportable Segment Disclosures, which requires a public entity to disclose significant segment expenses and other segment items on an annual and interim basis and provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker (“CODM”). The ASU doesnot change how a public entity identifies its operating segments, aggregates them, or applies the quantitative thresholds to determine its reportable segments. The new standard is effective for fiscal years beginning after* December 15, 2023,and interim periods within fiscal years beginning after December 15, 2024,with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We expect this ASU to only impact our disclosures withno* impacts to our results of operations, cash flows and financial condition.
In* December 2023,the FASB issued ASU2023*-09, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU2023-09 is effective for fiscal years beginning after* December 15, 2024,** maybe applied prospectively or retrospectively, and allows for early adoption. These requirements arenot* expected to have an impact on our financial statements, but will impact our income tax disclosures.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.